Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy

被引：0
|
作者：
Jorge E. Cortes
Florian H. Heidel
Walter Fiedler
B. Douglas Smith
Tadeusz Robak
Pau Montesinos
Anna Candoni
Brian Leber
Mikkael A. Sekeres
Daniel A. Pollyea
Roxanne Ferdinand
Weidong Wendy Ma
Thomas O’Brien
Ashleigh O’Connell
Geoffrey Chan
Michael Heuser
机构：
[1] Georgia Cancer Center,Department of Hematology and Oncology
[2] Otto-von-Guericke University Medical Center Magdeburg,Department of Hematology
[3] Internal Medicine II,Leukemia Program
[4] University Hospital Jena,Division of Hematology
[5] University Hospital Hamburg-Eppendorf,Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation
[6] Johns Hopkins Sidney Kimmel Comprehensive Cancer Center,undefined
[7] Medical University of Łódź and Copernicus Memorial Hospital,undefined
[8] Hospital Universitari i Politècnic La Fe,undefined
[9] Valencia,undefined
[10] Spain; CIBERONC,undefined
[11] Instituto Carlos III,undefined
[12] Azienda Sanitaria Universitaria Integrata di Udine,undefined
[13] Juravinski Hospital at Hamilton Health Sciences,undefined
[14] Cleveland Clinic,undefined
[15] University of Colorado School of Medicine,undefined
[16] Pfizer Oncology,undefined
[17] Hannover Medical School,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Glasdegib; Acute myeloid leukemia; Clinical trial; Disease response; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy
    Cortes, Jorge E.
    Heidel, Florian H.
    Fiedler, Walter
    Smith, B. Douglas
    Robak, Tadeusz
    Montesinos, Pau
    Candoni, Anna
    Leber, Brian
    Sekeres, Mikkael A.
    Pollyea, Daniel A.
    Ferdinand, Roxanne
    Ma, Weidong Wendy
    O'Brien, Thomas
    O'Connell, Ashleigh
    Chan, Geoffrey
    Heuser, Michael
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [2] Clinical Benefit of Glasdegib in Combination with Azacitidine or Low-Dose Cytarabine in Patients with Acute Myeloid Leukemia
    Zeidan, Amer M.
    Schuster, Michael W.
    Krauter, Jurgen
    Maertens, Johan A.
    Gyan, Emmanuel
    Joris, Magalie
    Menne, Tobias F.
    Vyas, Paresh
    Ma, Weidong Wendy
    O'Connell, Ashleigh
    Zeremski, Mirjana
    Kudla, Arthur
    Chan, Geoffrey
    Sekeres, Mikkael A.
    [J]. BLOOD, 2019, 134
  • [3] Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review
    Cortes, Jorge E.
    Candoni, Anna
    Clark, Richard E.
    Leber, Brian
    Montesinos, Pau
    Vyas, Paresh
    Zeidan, Amer M.
    Heuser, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3287 - 3305
  • [4] Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia
    Tremblay, Gabriel
    Daniele, Patrick
    Bell, Timothy
    Chan, Geoffrey
    Brown, Andrew
    Cappelleri, Joseph C.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (07) : 603 - 612
  • [5] Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
    Andrius Zucenka
    Kazimieras Maneikis
    Birute Pugaciute
    Ugne Ringeleviciute
    Austeja Dapkeviciute
    Linas Davainis
    Guoda Daukelaite
    Paulina Burzdikaite
    Vytautas Staras
    Laimonas Griskevicius
    [J]. Annals of Hematology, 2021, 100 : 1195 - 1202
  • [6] Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
    Zucenka, Andrius
    Maneikis, Kazimieras
    Pugaciute, Birute
    Ringeleviciute, Ugne
    Dapkeviciute, Austeja
    Davainis, Linas
    Daukelaite, Guoda
    Burzdikaite, Paulina
    Staras, Vytautas
    Griskevicius, Laimonas
    [J]. ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1195 - 1202
  • [7] LOW-DOSE CYTARABINE IN ACUTE MYELOID-LEUKEMIA
    MANOHARAN, A
    LEYDEN, MJ
    SULLIVAN, J
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 1984, 141 (10) : 643 - 646
  • [8] Clinical Benefit of Glasdegib Plus Low-Dose Cytarabine in Patients with De Novo and Secondary Acute Myeloid Leukemia: Long-Term Analysis of a Phase 2 Randomized Trial
    Heuser, Michael
    Fiedler, Walter
    Sekeres, Mikkael A.
    Montesinos, Pau
    Leber, Brian
    Merchant, Akil
    Papayannidis, Cristina
    Perez-Simon, Jose A.
    Hoang, Caroline J.
    Ma, Weidong Wendy
    Zeremski, Mirjana
    O'Connell, Ashleigh
    Chan, Geoffrey
    Cortes, Jorge E.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S231 - S231
  • [9] Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
    Michael Heuser
    B. Douglas Smith
    Walter Fiedler
    Mikkael A. Sekeres
    Pau Montesinos
    Brian Leber
    Akil Merchant
    Cristina Papayannidis
    José A. Pérez-Simón
    Caroline J. Hoang
    Thomas O’Brien
    Weidong Wendy Ma
    Mirjana Zeremski
    Ashleigh O’Connell
    Geoffrey Chan
    Jorge E. Cortes
    [J]. Annals of Hematology, 2021, 100 : 1181 - 1194
  • [10] Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacists
    Relias, Valerie
    McBride, Ali
    Newman, Matthew J.
    Paul, Shilpa
    Saneeymehri, Seyyedeh
    Stanislaus, Genique
    Tobin, Jennifer
    Hoang, Caroline J.
    Ryan, Joanne C.
    Galinsky, Ilene
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 658 - 672
12345